Figure 2From: First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancerKaplan-Meier curve of OS for adenocarcinoma patients (green) and non-adenocarcinoma (pink). Adenocarcinoma was remarkably longer than that of non-adenocarcinoma (P = 0.0149).Back to article page